GIHN || Liver Disease

Oxidized low-density lipoprotein predicted chronic HCV interferon response

Posted on: 01/05/2015 - 05:01

Oxidized low-density lipoprotein prevented hepatitis C virus from entering liver cells and predicted interferon response among patients with chronic H... More »

Field of Interest: Gastroentero...

Type: News Item

Threefold increase in cirrhosis risk with HCV

Posted on: 04/02/2015 - 15:26

Individuals with hepatitis C infection are three times more likely to develop cirrhosis than are those who are hepatitis C negative, and fibrosis prog... More »

Field of Interest: Gastroentero...

Type: News Item

Human liver cells can induce antiviral reaction against hepatitis C

Posted on: 01/02/2015 - 06:01

Immunity against the hepatitis C virus can be induced by cultured primary human liver sinusoidal endothelial cells, according to a study published in ... More »

Field of Interest: Gastroentero...

Type: News Item

Vasopressor terlipressin helped patients with cirrhosis, shock

Posted on: 04/12/2014 - 21:34

BOSTON – Terlipressin proved noninferior to noradrenaline as a vasopressor for patients with cirrhosis and septic shock in an open-label study that randomized 84 patients. Terlipressin also seemed...

Field of Interest: Gastroentero...

Type: News Item

Aramchol shows promise for NAFLD; resveratrol disappoints

Posted on: 01/12/2014 - 20:00

Administration of a novel fatty acid–bile acid conjugate safely and significantly reduced liver fat content in patients with nonalcoholic fatty liver disease in a phase II trial. Administration of...

Field of Interest: Gastroentero...

Type: News Item

Interferon-free regimens yield 96%-100% SVRs

Posted on: 01/08/2014 - 05:01

Two interferon-free combination therapies yielded sustained virologic responses of 96%-100% in an international, open-label, phase III, randomized trial involving 186 patients with refractory...

Field of Interest: Gastroentero...

Type: News Item

Genotype 3 HCV linked to greater risk of cirrhosis, liver cancer

Posted on: 23/07/2014 - 17:45

Veterans with genotype 3 hepatitis C virus infection were 31% more likely to develop cirrhosis and 80% more likely to develop liver cancer than were patients with genotype 1 infection, reported the...

Field of Interest: Gastroentero...

Type: News Item

Nucleoside analogues’ benefits in HBV vary

Posted on: 01/07/2014 - 05:01

Nucleoside analogues are effective at preventing hepatocellular carcinoma in hepatitis B, but all are not equal when it comes to overall mortality and liver transplant, according to two new studies...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Oral drugs tackle hepatitis C genotypes 2, 3

Posted on: 07/05/2014 - 19:30

CHICAGO – The oral drug duo of sofosbuvir and ribavirin produced good cure rates in a study of 419 patients with hepatitis C genotype 2 or 3. Dr. Bruce R. Bacon, who was not involved in the study,...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Oral drugs tackle hepatitis C genotypes 2, 3

Posted on: 07/05/2014 - 19:30

Field of Interest: Endocrinology

Type: News Item

Oxidized low-density lipoprotein predicted chronic HCV interferon response

Threefold increase in cirrhosis risk with HCV

Human liver cells can induce antiviral reaction against hepatitis C

Vasopressor terlipressin helped patients with cirrhosis, shock

Aramchol shows promise for NAFLD; resveratrol disappoints

Interferon-free regimens yield 96%-100% SVRs

Genotype 3 HCV linked to greater risk of cirrhosis, liver cancer

Nucleoside analogues’ benefits in HBV vary

VIDEO: Oral drugs tackle hepatitis C genotypes 2, 3

VIDEO: Oral drugs tackle hepatitis C genotypes 2, 3

Newsletters

Latest Newsletters

You are here

GIHN || Liver Disease

Newsletters

Latest Newsletters